These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30914057)

  • 1. Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma.
    Ladanyi M; Sanchez Vega F; Zauderer M
    Genome Med; 2019 Mar; 11(1):18. PubMed ID: 30914057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.
    Shrestha R; Nabavi N; Lin YY; Mo F; Anderson S; Volik S; Adomat HH; Lin D; Xue H; Dong X; Shukin R; Bell RH; McConeghy B; Haegert A; Brahmbhatt S; Li E; Oo HZ; Hurtado-Coll A; Fazli L; Zhou J; McConnell Y; McCart A; Lowy A; Morin GB; Chen T; Daugaard M; Sahinalp SC; Hach F; Le Bihan S; Gleave ME; Wang Y; Churg A; Collins CC
    Genome Med; 2019 Feb; 11(1):8. PubMed ID: 30777124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic BAP1 Loss as a Predictive Biomarker of Overall Survival in Patients With Malignant Pleural Mesothelioma Treated With Chemotherapy.
    Ghafoor A; Hassan R
    J Thorac Oncol; 2022 Jul; 17(7):862-864. PubMed ID: 35750452
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma.
    Wu D; Hiroshima K; Yusa T; Ozaki D; Koh E; Sekine Y; Matsumoto S; Nabeshima K; Sato A; Tsujimura T; Yamakawa H; Tada Y; Shimada H; Tagawa M
    Ann Diagn Pathol; 2017 Feb; 26():31-37. PubMed ID: 28038708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma.
    Andrici J; Jung J; Sheen A; D'Urso L; Sioson L; Pickett J; Parkhill TR; Verdonk B; Wardell KL; Singh A; Clarkson A; Watson N; Toon CW; Gill AJ
    Hum Pathol; 2016 May; 51():9-15. PubMed ID: 27067777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Tumor-Specific Neo-Antigen Caused by a Frameshift Mutation in BAP1 Is a Potential Personalized Biomarker in Malignant Peritoneal Mesothelioma.
    Lai J; Zhou Z; Tang XJ; Gao ZB; Zhou J; Chen SQ
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting BAP1: a new paradigm for mesothelioma.
    Schunselaar LM; Zwart W; Baas P
    Lung Cancer; 2017 Jul; 109():145-146. PubMed ID: 28342657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of expression of BAP1 predicts longer survival in mesothelioma.
    Farzin M; Toon CW; Clarkson A; Sioson L; Watson N; Andrici J; Gill AJ
    Pathology; 2015 Jun; 47(4):302-7. PubMed ID: 25938359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Loss of BRCA associated protein 1 expression in malignant mesothelioma and its diagnostic application].
    Guo ZY; Sun WY; Michele Y; Zhang JL; Hu D; Su HN; Yang WM; Mao W
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):699-703. PubMed ID: 29050072
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma.
    Badhai J; Landman N; Pandey GK; Song JY; Hulsman D; Krijgsman O; Chandrasekaran G; Berns A; van Lohuizen M
    Cancer Res Commun; 2024 Jan; 4(1):18-27. PubMed ID: 38054839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.
    Napolitano A; Pellegrini L; Dey A; Larson D; Tanji M; Flores EG; Kendrick B; Lapid D; Powers A; Kanodia S; Pastorino S; Pass HI; Dixit V; Yang H; Carbone M
    Oncogene; 2016 Apr; 35(15):1996-2002. PubMed ID: 26119930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression of BAP1 is very rare in non-small cell lung carcinoma.
    Andrici J; Parkhill TR; Jung J; Wardell KL; Verdonk B; Singh A; Sioson L; Clarkson A; Watson N; Sheen A; Farzin M; Toon CW; Gill AJ
    Pathology; 2016 Jun; 48(4):336-40. PubMed ID: 27114369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer.
    Owen D; Sheffield BS; Ionescu D; Churg A
    Hum Pathol; 2017 Feb; 60():82-85. PubMed ID: 27984124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
    Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
    Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
    Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1 in solid tumors.
    Di Nunno V; Frega G; Santoni M; Gatto L; Fiorentino M; Montironi R; Battelli N; Brandi G; Massari F
    Future Oncol; 2019 Jun; 15(18):2151-2162. PubMed ID: 31159579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [BRCA1 associated protein 1 (BAP1) expression in pleural diffuse malignant mesothelioma: A comparative cytological and histological analyses on 50 patients].
    Jaouen A; Thivolet-Bejui F; Chalabreysse L; Piaton E; Traverse-Glehen A; Isaac S; Decaussin-Petrucci M; Depaepe L; Fontaine J; Remy I; Maury JM; Brevet M
    Ann Pathol; 2016 Apr; 36(2):111-9. PubMed ID: 26995100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesothelioma families without inheritance of a BAP1 predisposing mutation.
    Ascoli V; Cozzi I; Vatrano S; Izzo S; Giorcelli J; Romeo E; Carnovale-Scalzo C; Grillo LR; Facciolo F; Visca P; Papotti M; Righi L
    Cancer Genet; 2016 Sep; 209(9):381-387. PubMed ID: 27751355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
    Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.